Aspen Pharmacare, Africa’s largest drug maker, will reconsider in September the decision to suspend dividend payments.

The company made the announcement on Friday. The possible resumption of dividend payments in the 2020 financial year comes as the group’s efforts to reduce its hefty debt appears to be paying off...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.